-
公开(公告)号:US12038431B2
公开(公告)日:2024-07-16
申请号:US18054595
申请日:2022-11-11
Applicant: MEDIC LIFE SCIENCES INC.
Inventor: Kyuho Han , Hong-Pyo Lee
CPC classification number: G01N33/5008 , C07K19/00 , C12N15/1037 , G01N33/5011 , G01N33/502 , C07K2319/03 , C07K2319/035 , G01N2500/04
Abstract: The present disclosure provides a high-throughput screening system and method for identification of novel drugs and drug targets. The method enables large-scale analysis of interactions between allogeneic pairs of target cells and immune cells by using an immune-bridge protein, library of guide RNA, and/or 3D tumor model.
-
公开(公告)号:US20230083853A1
公开(公告)日:2023-03-16
申请号:US18054595
申请日:2022-11-11
Applicant: MEDIC LIFE SCIENCES INC.
Inventor: Kyuho Han , Hong-Pyo Lee
Abstract: The present disclosure provides a high-throughput screening system and method for identification of novel drugs and drug targets. The method enables large-scale analysis of interactions between allogeneic pairs of target cells and immune cells by using an immune-bridge protein, library of guide RNA, and/or 3D tumor model.
-
公开(公告)号:US11802866B2
公开(公告)日:2023-10-31
申请号:US17811290
申请日:2022-07-07
Applicant: MEDIC LIFE SCIENCES INC.
Inventor: Kyuho Han , Hong-Pyo Lee
CPC classification number: G01N33/5008 , C07K19/00 , C12N15/1037 , G01N33/502 , G01N33/5011 , C07K2319/03 , C07K2319/035 , G01N2500/04
Abstract: The present disclosure provides a high-throughput screening system and method for identification of novel drugs and drug targets. The method enables large-scale analysis of interactions between allogeneic pairs of target cells and immune cells by using an immune-bridge protein, library of guide RNA, and/or 3D tumor model.
-
公开(公告)号:US20230027352A1
公开(公告)日:2023-01-26
申请号:US17811290
申请日:2022-07-07
Applicant: MEDIC LIFE SCIENCES INC.
Inventor: Kyuho Han , Hong-Pyo Lee
Abstract: The present disclosure provides a high-throughput screening system and method for identification of novel drugs and drug targets. The method enables large-scale analysis of interactions between allogeneic pairs of target cells and immune cells by using an immune-bridge protein, library of guide RNA, and/or 3D tumor model.
-
-
-